|
Market Closed -
Sao Paulo
06:38:37 06/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 78.80 BRL | -8.22% |
|
-8.61% | +0.72% |
| 28/09 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 23/09 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.02% | -3.52% | -0.54% | -5.83% | +6.37% | +36.11% | +111.11% | +395.01% | +1,298.31% | 1,019B | |
| -1.21% | -6.99% | -8.10% | -3.84% | +22.22% | +34.08% | +60.96% | +58.50% | +112.23% | 610B | |
| +1.12% | -0.20% | +3.63% | +1.80% | +16.31% | +13.62% | +80.24% | +142.68% | +319.25% | 470B | |
| -3.30% | -6.15% | -7.18% | +7.70% | +32.57% | +56.45% | +34.69% | +71.00% | +122.20% | 344B | |
| +1.26% | +1.06% | -0.17% | +6.39% | +7.56% | +22.40% | +42.28% | +1.00% | +47.51% | 336B | |
| +1.06% | -2.78% | -6.30% | -6.03% | +7.26% | +11.12% | +33.02% | +55.54% | +52.97% | 266B | |
| +2.33% | -3.32% | -0.22% | -14.78% | -12.86% | -5.58% | +9.82% | +36.89% | +139.08% | 241B | |
| -0.01% | -3.62% | -7.83% | +7.71% | +23.12% | +35.28% | +52.02% | +90.21% | +140.96% | 218B | |
| -0.08% | -4.98% | -4.22% | +10.18% | +17.83% | +28.34% | +93.61% | +114.58% | +86.45% | 179B | |
| +0.54% | -1.49% | -17.08% | -22.80% | -23.78% | -35.87% | -61.58% | -20.19% | +81.28% | 164B | |
| -1.40% | -4.56% | -3.66% | +12.71% | +10.08% | +0.15% | -18.11% | -35.23% | -19.14% | 156B | |
| -0.24% | -4.58% | -7.80% | -4.65% | +11.06% | +24.85% | +41.78% | +184.45% | +474.44% | 128B | |
| -3.83% | -7.94% | -11.99% | +1.17% | +9.03% | +29.39% | +4.24% | -0.57% | +7.34% | 120B | |
| +1.46% | +6.91% | +0.82% | +16.43% | +11.60% | +24.03% | +105.35% | +361.84% | +452.57% | 107B | |
| +1.80% | -0.29% | -5.85% | -4.36% | -13.85% | -16.93% | -30.27% | -14.09% | +3.61% | 93.99B | |
| +0.67% | -4.58% | -3.62% | -10.69% | -2.93% | +9.59% | +18.11% | +2.64% | -15.69% | 93.19B | |
| +6.95% | +3.01% | +39.62% | +154.78% | +589.08% | +613.27% | +97.35% | -38.81% | - | 81.13B | |
| -1.19% | -3.43% | -12.23% | +11.04% | -5.88% | +21.08% | -12.59% | +31.87% | +85.04% | 72.54B | |
| +4.21% | +2.87% | +4.63% | -1.02% | +15.29% | +17.60% | -9.68% | -24.31% | +46.64% | 66.31B | |
| Average | +0.87% | -2.83% | -2.53% | +8.20% | +37.90% | +48.37% | +34.33% | +74.37% | +190.84% | 250.76B | |
| Weighted average by Cap. | +0.93% | -3.24% | -3.04% | +1.50% | +20.30% | +33.68% | +55.16% | +135.08% | +388.89% |
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
